Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

BlueMountain Capital Management, LLC

2. Date of Event Requiring Statement (MM/DD/YYYY) 11/8/2019

3. Issuer Name and Ticker or Trading Symbol

AdaptHealth Corp. [AHCO]

(Last) (First) (Middle)

280 PARK AVENUE, 12TH FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

NEW YORK, NY 10017

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock ⁽¹⁾⁽²⁾⁽³⁾	3647353	I	Footnotes ⁽¹⁾⁽²⁾⁽³⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:
(1)	The filing of this Form 3 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any share of Class A Common Stock, par value $0.0001 per share "Class A Common Stock"), of AdaptHealth Corp. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
(2)	BMCM is the investment manager of each of: (i) BMSB L.P. ("BMSB"), which is the direct beneficial owner of 2,115,972 shares of Class A Common Stock; (ii) BlueMountain Fursan Fund L.P. ("FRSN"), which is the direct beneficial owner of 842,768 shares of Class A Common Stock; (iii) BlueMountain Foinaven Master Fund L.P. ("BMFV"), which is the direct beneficial owner of 688,613 shares of Class A Common Stock; and (iv) BlueMountain Summit Opportunities Fund II (US) L.P. Fund L.P. (together with BMSB, FRSN and BMFV, the "Funds"), which is the direct beneficial owner of 150,581 shares of Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), of the Issuer. BMCM, although it directs the voting and disposition of the Class A Common Stock and Class B Common Stock held by the Funds, only receives an asset-based fee relating to the Class A Common Stock and Class B Common Stock held by the Funds.
(3)	Pursuant to the terms of the Exchange Agreement dated as of November 8, 2019 by and among the Issuer, AdaptHealth Holdings LLC, a subsidiary of the Issuer, and the other parties thereto, each share of Class B Common Stock, when combined with a common unit representing limited liability company interests in AdaptHealth Holdings LLC, is exchangeable at any time for one share of Class A Common Stock or, at the Issuer's election, the cash equivalent to the market value of one share of Class A Common Stock. The Class B Common Stock has no expiration date.

Remarks:
Dale Wolf serves as a director of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 3.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
BlueMountain Capital Management, LLC 280 PARK AVENUE, 12TH FLOOR NEW YORK, NY 10017	X

Signatures
BlueMountain Capital Management, LLC, By: /s/ Eric M. Albert, Chief Compliance Officer		11/18/2019
^**Signature of Reporting Person		Date